Drug Combination Details
| General Information of the Combination (ID: C21874) | |||||
|---|---|---|---|---|---|
| Name | Tretinoin | + | Imiquimod + 5-fluorouracil | ||
| Click to Show/Hide the Each NP or Drug Information of This Combination | |||||
| Name | Tretinoin NP Info | Drug Info | |||
| Structure |
|
|
|||
| Name | Drug Info | ||||
| Structure |
|
|
|||
| Disease |
Melanoma
[ICD-11: 2C30]
|
Investigative | [1] | ||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. Enhancing Drug Efficacy by This Combination | ||||||
| Achieving Therapeutic Synergy | Click to Show/Hide | |||||
| Experiment 1 Reporting the Effect of This Combination | [1] | |||||
| In-vivo Model | A case report | |||||
| Experimental
Result(s) |
Combination of imiquimod, 5-fluorouracil, and tretinoin is an effective viable treatment modality for treating melanoma in situ during a pandemic with telemedicine. | |||||
| References | ||||
|---|---|---|---|---|
| Reference 1 | Treating Melanoma in Situ During a Pandemic with Telemedicine and a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin. Dermatol Ther (Heidelb). 2021 Feb;11(1):307-314. | |||
